Venture Capital Investors |
Company |
Amount |
Description |
EcoR1 Capital, GV, AbbVie Ventures, The Mark Foundation for Cancer Research, NS Investment, Droia Ventures, Atlas Venture, The Column Group |
Accent Therapeutics |
$63M |
Lexington, MA-based developer of cancer therapies |
Viking Global Investors, Bain Capital, Ziff Capital |
Affinivax |
$120M |
Lexington, MA-based vaccine developer |
OMERS, Echo Health Ventures, the California Medical Association, Meritech Capital Partners, CVF, GV |
Aledade |
$64M |
Bethesda, MD-based network of accountable care organizations |
Coatue Management, Altimeter Capital, Franklin Templeton, Index Ventures, Sequoia Capital |
Confluent |
$250M |
Mountain View, CA-based data event streaming platform |
Jimmy Iovine, NTWRK |
FaZe Clan |
$40M |
Los Angeles, CA-based esports organization |
Accel, Emergence Capital, Thrive Capital, FirstMark Capital, Slack, MSD Capital |
Guru |
$30M |
Philadelphia, PA-based provider of collaborative knowledge management software |
WRVI Capital, Cota Capital, DNX Ventures |
Movandi |
$27M |
Irvine, CA-based developer of 5G millimeter wave networks |
Sofinnova Partners, AbbVie Ventures, Dementia Discovery Fund, Mission Bay Capital, Alexandria Venture Investments |
Nitrome |
$38M |
San Francisco, CA-based drug startup focused on a class of enzymes to target Parkinson’s disease and other age-related disorders |
Scaleworks, Conviction Capital |
Profitero |
$20M |
Boston, MA-based provider of ecommerce analytics SaaS for brands |
Accel, CRV |
Vercel |
$21M |
San Francisco, CA-based front-end development framework |
|